Delivery Order SPE2DB20D2002-SPE2DB24FL04X
Award Date 11/22/23
Potential Completion Date 11/24/23
Potential Value $1.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,805.54, is a Firm Fixed Price Delivery Order for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a diabetes medication. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,104.77 firm-fixed-price delivery order is for LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty medication. The contract has an ultimate completion date of January 7, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award, valued at $1,112.86, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the provision of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a diabetes medication. This award is not set-aside and represents an open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,022.80 delivery order contract is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a diabetes medication. The contract has a firm fixed price and is not set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML medical supplies. The contract, valued at $1,298.58, is a Firm Fixed Price Delivery Order with a completion date of January 17, 2024. The contract is not designated as a set-aside award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,396.82 firm fixed-price delivery order is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, with a period of performance through September 6, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,821.42, is a Delivery Order for the provision of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty medication. The contract has a firm fixed price pricing type and an ultimate completion date of March 21, 2025. This award is not associated with a set-aside designation, indicating open...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The $1,068.84 firm fixed price delivery order is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty pharmaceutical product. The award is part of an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that serves as the primary contract vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,022.80 firm fixed-price delivery order is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty medication. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for...
- This federal contract award is a Delivery Order from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $1,087.68 Firm Fixed Price contract is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a pharmaceutical product. The contract has an ultimate completion date of November 20, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB24FL04XDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,469.99, is a Firm Fixed Price Delivery Order for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award was not designated with a set-aside requirement, indicating open competition.
Generated 5/12/25, 10:37 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 11/22/23 |